NAGE vs USNA: stock comparison and AI forecast
Niagen Bioscience, Inc. (NAGE) and Usana Health Sciences Inc (USNA) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
NAGE Niagen Bioscience, Inc.
- Market Cap
- $164M
- P/E Ratio
- 14.8x
- Size
- small-cap
- AI Forecast
USNA Usana Health Sciences Inc
- Market Cap
- $256M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- USNA is 1.6 times larger than NAGE by market capitalization ($256M against $164M).
- NAGE turns 8.4% of its revenue into net income, against -2.4% for USNA.
- NAGE carries 0.31 times debt per unit of equity, against 0.25 times for USNA.
- Both companies share the SEC industry classification Medicinal Chemicals & Botanical Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | NAGE | USNA |
|---|---|---|
| Market Cap | $164M | $256M |
| P/E Ratio | 14.78x | – |
| P/B Ratio | 1.97x | 0.49x |
| EPS | $0.14 | $-1.10 |
| Book Value/Share | $1.05 | $28.49 |
| Revenue/Share | $1.55 | $49.43 |
| FCF/Share | – | $0.86 |
Profitability & Margins
| Metric | NAGE | USNA |
|---|---|---|
| ROE | 12.3% | -4.2% |
| ROA | 9.4% | -3.1% |
| ROIC | 5.2% | -0.2% |
| Gross Margin | 63.9% | 77.5% |
| Operating Margin | 3.9% | -0.1% |
| Net Margin | 8.4% | -2.4% |
| EBT Margin | 9.0% | 0.3% |
| Tax Rate | 7.4% | 1253.3% |
Financial Health
| Metric | NAGE | USNA |
|---|---|---|
| Current Ratio | 5.93x | 2.66x |
| Quick Ratio | 4.71x | 1.84x |
| D/E Ratio | 0.31x | 0.25x |
| Financial Leverage | 1.31x | 1.34x |
| Interest Coverage | 4086.0x | -86.6x |
| Working Capital | $83M | $175M |
Cash Flow
| Metric | NAGE | USNA |
|---|---|---|
| Operating Cash Flow | $5M | $28M |
| Free Cash Flow | – | $16M |
| Capital Spending | – | -$12M |
| OCF Growth YoY | -77.2% | -57.5% |
| FCF Growth YoY | – | -75.7% |
| FCF/Sales | – | 1.7% |
| CapEx/Sales | – | 1.3% |
Operational Efficiency
| Metric | NAGE | USNA |
|---|---|---|
| Asset Turnover | 1.13x | 1.30x |
| Receivables Turnover | 17.9x | 273.7x |
| Inventory Turnover | 2.1x | 2.4x |
| Fixed Assets Turnover | 100.6x | 9.7x |
| Days Sales Outstanding | 20 days | 1 days |
| Days Inventory | 170 days | 153 days |
| Payables Period | 95 days | 27 days |
| Cash Conversion Cycle | 95 days | 127 days |
Income Statement
| Metric | NAGE | USNA |
|---|---|---|
| Total Revenue | $122M | $913M |
| Operating Income | $5M | -$1M |
| Net Income | $10M | -$22M |
| R&D Expense | $6M | – |
| SG&A Expense | $41M | $335M |
| Cost of Goods Sold | $44M | $206M |
Dividend & Shareholder Information
| Metric | NAGE | USNA |
|---|---|---|
| Shares Outstanding | 79M | 18M |
| Net Income Growth | -49.9% | -155.0% |
| EPS Growth | 0.0% | -244.7% |
NAGE vs USNA: stock comparison and AI forecast
Which is bigger, NAGE or USNA?
USNA is 1.6 times larger than NAGE by market capitalization ($256M against $164M).
Which one does Intratio's AI model rank higher, NAGE or USNA?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.